Inclusion Criteria:  Patient ≥18 years old Male or non-pregnant, non-lactating, postmenopausal or surgically sterilized females Subjects scheduled to undergo primary, elective total knee arthroplasty or total hip arthroplasty Subjects provide informed consent, which will consist of reading, signing, and dating the informed consent document after the Investigator, sub-Investigator or other designated study staff member has explained the study procedures, risks, and contact information Subjects deemed able to understand and comply with study visit schedule and procedures  Exclusion Criteria:  Local skin conditions such as dermatitis, eczema, psoriasis that, in the opinion of the investigator, will make it difficult to assess wound complications or local skin reactions following surgery Pregnant, lactating females, or females of childbearing potential not willing to practice an effective method of contraception Active or previous infection in the skin or the knee or hip to be operated, evidence of gangrene Subjects who have participated in this trial previously and who were withdrawn Subjects with known allergies to product components including cyanoacrylate, formaldehyde, benzalkonium chloride or have known allergies or skin sensitivity to the Convatec Aquacel dressing. Inability or refusal to provide informed consent or follow study and wound care instructions